Source: Rybelsus (DailyMed), Wegovy (DailyMed) Rybelsus and Wegovy drug interactions Semaglutide, the active ingredient in Rybelsus and Wegovy, can lower blood sugar levels and may cause hypoglycemia (low blood sugar)
Diabetes Care 47(8):13501359 Mather KJ, Mari A, Weerakkody G, Heise T, DeVries JH, Urva S, Coskun T, Milicevic Z, Haupt A, Thomas MK (2025) Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis
Konikoff FM, Paitan Y, Gabay G, Reshef L, Naftali T, Gophna U
The most effective approach blends nutrition, skincare, hormone optimization, and dermatology care into one proactive strategy
This is more likely to happen in leaner patients if they dont pinch the skin
Semaglutide offers more significant weight loss compared to many other weight loss medications